Alnara Pharmaceuticals
Cambridge · Founded 2008
About Alnara Pharmaceuticals
Alnara Pharmaceuticals, Inc. is dedicated to developing novel protein therapeutics for the treatment of metabolic diseases. The company's innovative approach focuses on designing effective protein therapies that can be orally delivered directly to the gastrointestinal tract without being absorbed into the bloodstream.
Company Facts
- Founded: 2008
- Legal name: Alnara Pharmaceuticals, Inc.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $55.0M
- Funding stage: M&A
- Last round: Series B (Jan 2010)
- Website: alnara.com
- Phone: 617-349-3690
Social Profiles
Canonical: https://fsome.com/organization/alnara-pharmaceuticals-8372659 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.